EP3347032
TERLIPRESSIN FOR THE TREATMENT OF ASCITES DUE TO LIVER CIRRHOSIS ADMINISTERED AS A CONTINUOUS INFUSION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
30.6.2016EP published:
29.11.2023EP application number:
16818751.6
EPO information:
European Patent Register
Max expiry date:
29.6.2036
Title in English:
TERLIPRESSIN FOR THE TREATMENT OF ASCITES DUE TO LIVER CIRRHOSIS ADMINISTERED AS A CONTINUOUS INFUSIONLanguage of the patent:
English
Timeline
Today
30.6.2016EP application
29.11.2023EP Publication
Owner
Name:
BioVie Inc.Address:
100 Cumming Center, Suite 247-C, Beverly, MA 01915, US
Inventor
Name:
ANGELI, PaoloAddress:
35135 Padova, IT
Name:
MARKHAM, PenelopeAddress:
Cliffton, VA 20124, US
Name:
ADAMS, JonathanAddress:
Chicago, IL 60605, US
Priority
Number:
201562186638 PDate:
30.6.2015Country:
US
Number:
201562267510 PDate:
15.12.2015Country:
US
Number:
201662321558 PDate:
12.4.2016Country:
US
Classification
Categories:
A61K 38/095, A61K 38/08, C07K 7/16, A61P 1/16, A61P 1/00